Are there specific considerations or contraindications for prescribing HRT to patients with MCAS?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18527484
Cited by: 0

Abstract

When prescribing HRT to patients with MCAS, careful consideration of hormone type and potential exacerbation of symptoms is key due to estrogen's effect on mast cell activation.

Fields of Study & Subjects

Mast cells and histamine Menopause: Health Impacts and Treatments Estrogen and related hormone effects

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
8 February 2026